	Lack of association between unhealthy vaginal pH and bacterial vaginosis positive status. J Infect Dev Ctries Msomi N, Mabaso N, Nyirenda M, Abbai N. PMID: 42715275 [PubMed - indexed for MEDLINE]
	Predictors of anal and cervical cancer screening uptake among adults with and without HIV: survey of a community-based health clinic network. Cancer Causes Control Lin YC, Hume E, Boxtha C, Commaroto SA, Lael M, Christy SM, Vadaparampil ST, Giuliano AR, Coghill AE, Schabath MB, Vidrine DJ, Peterson J, DiPalmo S, Joshi H, Shukla P, Vidrine JI, Islam JY. PMID: 42714682 [PubMed - indexed for MEDLINE]
	Serum, cell-free, HPV-human DNA junction detection and HPV typing for predicting and monitoring cervical cancer recurrence. Elife Van Arsdale AR, Meshcheryakova O, Gallego S, Maggi EC, Harmon B, Kuo DYS, Van Doorslaer K, Einstein MH, Haas BJ, Montagna C, Lenz J. PMID: 42713958 [PubMed - indexed for MEDLINE]
	Development of a SERS-based diagnostic tool for infectious vaginitis via intelligent analysis of vaginal fluid spectra. Anal Chim Acta Xie Y, Chen J, Zhou Z, Wang Y, Hong Y, Tang J, Chen H, Wang L. PMID: 42702475 [PubMed - indexed for MEDLINE]
	Exploring Indonesian midwives' training experiences and knowledge related to cervical screening and HPV DNA testing in East Nusa Tenggara province. Womens Health (Lond) Frans SO, Utomo A, Bennett LR. PMID: 42702001 [PubMed - indexed for MEDLINE]
	Clinical features of Escherichia coli positive calcium oxalate stones and effects of outer membrane vesicles on tubular epithelial injury and crystal adhesion. Front Cell Infect Microbiol Ding X, Du Q, Niu X, Zhang E, Li J, Chen G, Ji C, Hu W. PMID: 42694201 [PubMed - indexed for MEDLINE]
	Perceived Feasibility and Acceptability of a Self-Collected HPV DNA Testing Policy for Cervical Cancer Screening in Thailand. J Prim Care Community Health Kositamongkol C, Mepramoon E, Kanchanasurakit S, Talungchit P, Chaopotong P, Kengkla K, Chaisathaphol T, Saokaew S, Phisalprapa P. PMID: 42693793 [PubMed - indexed for MEDLINE]
	HPV genotype distribution and associated risk factors in women from Karad, Maharashtra: A molecular characterisation study. Indian J Med Res Deshmukh VN, Patil SR, Hinge DD, Jadhav PS. PMID: 42690849 [PubMed - indexed for MEDLINE]
	Understanding the association between immune-modulating helminths and HPV or cervical cancer: A scoping review. PLoS Negl Trop Dis Frank A, Correa-Mendez M, Livinski AA, Duncan K, Clark EH, Gravitt PE. PMID: 42685064 [PubMed - indexed for MEDLINE]
	Assessing the Capacity of Health Facilities to Deliver Concomitant HPV Vaccination and HPV-Based Cervical Screening Services to Vulnerable Populations - An Implementation Research Protocol. Cancer Control Mosquera I, Tisler A, Ramirez AT, Elfstrom KM, Dillner J, Robles C, Peremiquel-Trillas P, Bosch X, Gini A, Baussano I, Bardou M, Hassine A, Franc C, Menvielle G, Tranberg M, Axelsen AL, Kirkegaard P, Andersen B, Petersen LK, Glintborg D, Martin-Iguacel R, Johansen IS, Christensen LL, Jespersen S, Hauge E, Rotar I, Muresan D, Baban A, Taut D, Redmond NM, Basu P. PMID: 42683830 [PubMed - indexed for MEDLINE]
	DNA Methylation Testing in Cervical Cancer: A Triage Tool for HPV-Based Screening and Post-Treatment Surveillance. J Obstet Gynaecol Res Xu Y, Zhou X, Guo L, Lyu R. PMID: 42681848 [PubMed - indexed for MEDLINE]
	Occurrence and relevance of Gardnerella vaginalis in urine cultures of kidney transplant recipients- a retrospective cohort analysis. BMC Microbiol Klein S, Deininger S, Schröter I, Nurjadi D, Sommerer C. PMID: 42681605 [PubMed - indexed for MEDLINE]
	FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions. Int J Gynecol Cancer Pareja R, Heredia F, Sánchez-Díaz E, Cuello MA, de Sanjosé S, Jerónimo J, Garland SM, Pino MD, Fletcher A, Torné A, Levin G, Flowers L, Ndukwe MI, Trujillo LM, Wilailak S, Bhatla N, Fotopoulou C, Schmalfeldt B, Sánchez GI, Kyrgiou M, Petignat P, Abu-Rustum N. PMID: 42680632 [PubMed - indexed for MEDLINE]
	International Papillomavirus Society statement on reputed treatments for human papillomavirus infection and human papillomavirus-related diseases: evidence, risks, and standards for clinical evaluation. Int J Gynecol Cancer Arroyo Mühr LS, Mungo C, Chatzistamatiou K, Leung SOA, Garland SM, International Papillomavirus Society Policy Committee. PMID: 42680631 [PubMed - indexed for MEDLINE]
	Rapid molecular detection, prevalence and antimicrobial resistance of Ureaplasma urealyticum in genital tract specimens: a study at a district general hospital in China. Diagn Microbiol Infect Dis Zhao L, Jiang Y, Zong Y, Li R, Zhang H, Liu C, Li Z, Wang J. PMID: 42679638 [PubMed - indexed for MEDLINE]
	Benefits, harms, and cervical cancer elimination timing of human papillomavirus screening approaches tailored to birth cohort as a proxy for vaccination status in the United States: a comparative modeling study. J Natl Cancer Inst Monogr Simms KT, de Bondt D, Killen J, Sy S, Naslazi E, Regan MC, Burger EA, Kim JJ, Smith MA, de Kok IMCM, Canfell K. PMID: 42670626 [PubMed - indexed for MEDLINE]
	From evidence to practice: leveraging implementation science for transitioning to risk-adapted cervical cancer screening. J Natl Cancer Inst Monogr Adsul P, Adcock R. PMID: 42670625 [PubMed - indexed for MEDLINE]
	Cervical cancer screening in vaccinated populations: challenges and implications for low- and middle-income countries. J Natl Cancer Inst Monogr Almonte M, Tejada RA, Calderón A, Baena A. PMID: 42670624 [PubMed - indexed for MEDLINE]
	Deintensification of cervical cancer screening in the era of high human papillomavirus-vaccination coverage. J Natl Cancer Inst Monogr Bonde J, Castle PE. PMID: 42670623 [PubMed - indexed for MEDLINE]
	How to evaluate and select cervical screening and triage tests in vaccinated populations. J Natl Cancer Inst Monogr Wentzensen N, Arbyn M, Poljak M. PMID: 42670622 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 27496

Page 1 of 1375



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy